tradingkey.logo

Sonoma Pharmaceuticals Inc

SNOA
3.630USD
+0.050+1.40%
收盘 12/24, 13:00美东报价延迟15分钟
5.99M总市值
亏损市盈率 TTM

Sonoma Pharmaceuticals Inc

3.630
+0.050+1.40%

关于 Sonoma Pharmaceuticals Inc 公司

Sonoma Pharmaceuticals, Inc. is a global healthcare company. The Company is engaged in developing and producing stabilized hypochlorous acid (HOCl) products for a range of applications, including wound care, eye care, nasal care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. Its products are all classified as medical devices and categorized as prescription, over-the-counter (OTC) and office dispense products. It offers both prescription and OTC dermatology products, including Epicyn Facial Cleanser, Levicyn Dermal Spray, Levicyn Gel, Levicyn Spray Gel, Celacyn Scar Management Gel. In the United States, it offers Microcyn wound and skin care both as an OTC and prescription product. Its eyecare products include Acuiycn Eyelid and Eyelash Hygiene, and Ocucyn Eyelid and Eyelash Cleanser. MicrocynAH is an HOCl-based topical product that cleans, debrides and treats a wide spectrum of animal wounds and infections.

Sonoma Pharmaceuticals Inc简介

公司代码SNOA
公司名称Sonoma Pharmaceuticals Inc
上市日期Jan 26, 2007
CEOTrombly (Amy)
员工数量168
证券类型Ordinary Share
年结日Jan 26
公司地址5445 Conestoga Court, Suite 150
城市BOULDER
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编80301
电话18007599305
网址https://sonomapharma.com/
公司代码SNOA
上市日期Jan 26, 2007
CEOTrombly (Amy)

Sonoma Pharmaceuticals Inc公司高管

名称
名称/职务
职务
持股
持股变动
Dr. Jay E. Birnbaum, Ph.D.
Dr. Jay E. Birnbaum, Ph.D.
Independent Director
Independent Director
286.00
-0.35%
Mr. Jerry G. Mclaughlin
Mr. Jerry G. Mclaughlin
Lead Independent Director
Lead Independent Director
--
--
Mr. Philippe Weigerstorfer
Mr. Philippe Weigerstorfer
Independent Director
Independent Director
--
--
Mr. Jerry Dvonch
Mr. Jerry Dvonch
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Amy Trombly
Ms. Amy Trombly
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
名称
名称/职务
职务
持股
持股变动
Dr. Jay E. Birnbaum, Ph.D.
Dr. Jay E. Birnbaum, Ph.D.
Independent Director
Independent Director
286.00
-0.35%
Mr. Jerry G. Mclaughlin
Mr. Jerry G. Mclaughlin
Lead Independent Director
Lead Independent Director
--
--
Mr. Philippe Weigerstorfer
Mr. Philippe Weigerstorfer
Independent Director
Independent Director
--
--
Mr. Jerry Dvonch
Mr. Jerry Dvonch
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Amy Trombly
Ms. Amy Trombly
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--

收入明细

单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Human Care
3.56M
88.54%
Animal Care
460.00K
11.46%
地区USD
名称
营收
占比
Europe
1.47M
36.56%
United States
1.00M
25.03%
Asia
662.00K
16.49%
Latin America
564.00K
14.05%
Rest of the world
316.00K
7.87%
业务
地区
业务USD
名称
营收
占比
Human Care
3.56M
88.54%
Animal Care
460.00K
11.46%

股东统计

更新时间: 11月17日 周一
更新时间: 11月17日 周一
持股股东
股东类型
持股股东
持股股东
占比
The Vanguard Group, Inc.
1.23%
Geode Capital Management, L.L.C.
1.04%
DRW Securities, LLC
1.00%
Thornton (Bruce)
0.45%
Trombly (Amy Moss)
0.45%
其他
95.83%
持股股东
持股股东
占比
The Vanguard Group, Inc.
1.23%
Geode Capital Management, L.L.C.
1.04%
DRW Securities, LLC
1.00%
Thornton (Bruce)
0.45%
Trombly (Amy Moss)
0.45%
其他
95.83%
股东类型
持股股东
占比
Investment Advisor
2.31%
Individual Investor
1.24%
Investment Advisor/Hedge Fund
1.04%
Hedge Fund
0.09%
Research Firm
0.05%
其他
95.27%

机构持股

更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
34
106.22K
6.24%
+25.12K
2025Q2
39
61.63K
4.65%
-24.83K
2025Q1
40
54.41K
3.31%
-8.75K
2024Q4
40
41.45K
2.57%
-24.32K
2024Q3
41
49.08K
3.40%
+9.77K
2024Q2
40
43.04K
3.61%
+17.90K
2024Q1
38
20.55K
2.85%
-9.28K
2023Q4
36
27.53K
4.02%
+7.17K
2023Q3
35
18.63K
7.25%
-6.00K
2023Q2
37
18.70K
7.42%
+4.13K
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
The Vanguard Group, Inc.
18.79K
1.14%
--
--
Aug 31, 2025
Geode Capital Management, L.L.C.
17.62K
1.07%
+812.00
+4.83%
Jun 30, 2025
Thornton (Bruce)
7.72K
0.47%
-1.00
-0.01%
Jul 08, 2025
Trombly (Amy Moss)
7.68K
0.47%
--
--
Jul 08, 2025
Dvonch (Jerome J)
4.23K
0.26%
-1.00
-0.02%
Jul 08, 2025
Tower Research Capital LLC
1.00K
0.06%
-447.00
-30.89%
Jun 30, 2025
Dal (Poggetto John)
910.00
0.06%
+910.00
--
Jun 20, 2024
查看更多

持股ETF

机构名称
占比
暂无数据

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
Aug 28, 2024
Merger
20→1
Aug 28, 2024
Merger
20→1
Aug 28, 2024
Merger
20→1
Aug 28, 2024
Merger
20→1
公告日期
类型
比率
Aug 28, 2024
Merger
20→1
Aug 28, 2024
Merger
20→1
Aug 28, 2024
Merger
20→1
Aug 28, 2024
Merger
20→1

常见问题

Sonoma Pharmaceuticals Inc的前五大股东是谁?

Sonoma Pharmaceuticals Inc 的前五大股东如下:
The Vanguard Group, Inc.持有股份:18.79K,占总股份比例:1.14%。
Geode Capital Management, L.L.C.持有股份:17.62K,占总股份比例:1.07%。
Thornton (Bruce)持有股份:7.72K,占总股份比例:0.47%。
Trombly (Amy Moss)持有股份:7.68K,占总股份比例:0.47%。
Dvonch (Jerome J)持有股份:4.23K,占总股份比例:0.26%。

Sonoma Pharmaceuticals Inc的前三大股东类型是什么?

Sonoma Pharmaceuticals Inc 的前三大股东类型分别是:
The Vanguard Group, Inc.
Geode Capital Management, L.L.C.
DRW Securities, LLC

有多少机构持有Sonoma Pharmaceuticals Inc(SNOA)的股份?

截至2025Q3,共有34家机构持有Sonoma Pharmaceuticals Inc的股份,合计持有的股份价值约为106.22K,占公司总股份的6.24%。与2025Q2相比,机构持股有所增加,增幅为1.60%。

哪个业务部门对Sonoma Pharmaceuticals Inc的收入贡献最大?

在FY2026Q1,Human Care业务部门对Sonoma Pharmaceuticals Inc的收入贡献最大,创收3.56M,占总收入的88.54%。
KeyAI